Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
Repligen logo
RepligenRGEN
$6.74B+2.1%
ADMA Biologics logo
ADMA BiologicsADMA
$2.21B-52.5%
Revvity logo
RevvityRVTY
$12.88B-13.7%
TEC
Bio-TechneTECH
$8.26B-13.6%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

$414.3Mmarket cap+$270.9Mtotal debt−$165.9Mcash and equivalents=$519.22M

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s enterprise value?
Maravai LifeSciences Holdings, Inc. (MRVI) reported enterprise value of $519.22M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s enterprise value changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s enterprise value increased by 44.6% year-over-year, from $359.07M to $519.22M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s enterprise value has grown at a -35.4% compound annual growth rate (CAGR), from $5.52B to $619.14M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.